P F Schellhammer
Overview
Explore the profile of P F Schellhammer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
1703
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akaza H, Kurth K, Williams R, Hinotsu S, Jewett M, Naito K, et al.
Urol Oncol
. 2011 Jan;
4(4-5):121-9.
PMID: 21227217
No abstract available.
2.
Schellhammer P
Urol Oncol
. 2011 Jan;
4(3):73-9.
PMID: 21227197
The endpoints chosen for analysis of outcome following intravesical therapy can be quite varied. Precise definitions of endpoints are mandatory to permit any comparative assessment between agents or treatment regimens....
3.
deVere White R, Deitch A, Tesluk H, Blumensteinj B, Lowe B, Sagalowsky A, et al.
Urol Oncol
. 2011 Jan;
2(1):27-34.
PMID: 21224132
While 80% of transitional cell carcinomas (TCC) present as Ta Tl lesions, they account for only 15% of deaths caused by TCC. We have evaluated the ability of DNA ploidy...
4.
Lamm D, Blumenstein B, Crawford E, Crissman J, Lowe B, Smith Jr J, et al.
Urol Oncol
. 2011 Jan;
1(3):119-26.
PMID: 21224104
To compare the toxicity and efficacy of intravesical bacillus Calmette-Guérin (BCG) immunotherapy and mitomycin C (MMC) chemotherapy in the prophylaxis of recurrent transitional cell carcinoma, 469 patients with completely resected...
5.
6.
Fabozzi S, Kolm P, Schellhammer P
Urol Oncol
. 2011 Jan;
1(2):64-6.
PMID: 21224093
Casodex™ (ZENECA Limited) is a new antiandrogen presently under investigation for the treatment of metastatic prostate cancer. This study was designed to analyze response and possible prognostic significance of prostate...
7.
Wright Jr G, Haley C, Beckett M, Schellhammer P
Urol Oncol
. 2011 Jan;
1(1):18-28.
PMID: 21224086
Prostate-specific membrane antigen (PSMA) is a trans-membrane glycoprotein recognized by the murine monoclonal antibody (MAb) 7EII-C5.3 both in its native (CYT-351) and immunoconjugate form (CYT-356). Previous studies have shown that...
8.
Diaz J, Corica A, McKenzie R, Schellhammer P
Actas Urol Esp
. 2008 Feb;
31(9):1045-55.
PMID: 18257372
Introduction: The introduction of laparoscopic surgery as a procedure to perform radical prostatectomy needs an objective method to evaluate the suitability of this new surgical procedure. The traditional parameters, including...
9.
10.
Wright Jr G, Cazares L, Nasim S, Schellhammer P, Gong L, Vlahou A
Prostate Cancer Prostatic Dis
. 2002 Dec;
2(5-6):264-276.
PMID: 12497173
Improving early detection, diagnosis, treatment monitoring and prognosis of cancer will require rapid and high throughput detection, identification, and measurement of multiple biomarkers. In this study, we demonstrate the versatility...